Molecular Mechanism of Secondary Endocrine Resistance in Luminal Breast Cancer

OBJECTIVE: The molecular mechanism of secondary resistance in Luminal breast cancer was studied to provide new ideas for the treatment of breast cancer. METHODS: The sensitivity of the downregulation of myeloid leukemia factor 1-interacting proteins (MLF1IP) to Tamoxifen (TAM) was tested by the Cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Minhua, Ding, Jinhua, Wen, Limu, Zhou, Yuxin, Wu, Weizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990544/
https://www.ncbi.nlm.nih.gov/pubmed/33816619
http://dx.doi.org/10.1155/2021/6618519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990544/
https://www.ncbi.nlm.nih.gov/pubmed/33816619
http://dx.doi.org/10.1155/2021/6618519

Ejemplares similares